54 related articles for article (PubMed ID: 904751)
1. Hyperuricaemia as an index of the response to chemotherapy in solid tumors.
Wiktor-Jedrzejczak W; Siekierzynski M; Piechota W
Neoplasma; 1977; 24(4):457-60. PubMed ID: 904751
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
3. Curative cancer chemotherapy.
Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
5. Curative and palliative aspects of regional chemotherapy in combination with surgery.
Müller H; Hilger R
Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
[TBL] [Abstract][Full Text] [Related]
6. [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
Słowik-Gabryelska A; Szczepanik A; Kalicka A
Pol Merkur Lekarski; 1999 Jan; 6(31):18-22. PubMed ID: 10344148
[TBL] [Abstract][Full Text] [Related]
7. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
8. Combination versus alternating chemotherapy in small-cell lung cancer.
Lai SL; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.
Young SD; Whissell M; Noble JC; Cano PO; Lopez PG; Germond CJ
Clin Cancer Res; 2006 May; 12(10):3092-8. PubMed ID: 16707607
[TBL] [Abstract][Full Text] [Related]
10. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
[TBL] [Abstract][Full Text] [Related]
12. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
Boher JM; Pujol JL; Grenier J; Daurès JP
Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
[TBL] [Abstract][Full Text] [Related]
13. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
[TBL] [Abstract][Full Text] [Related]
14. Rationale for the use of chemotherapy in non-small cell lung cancer.
Miller TP
Semin Oncol; 1990 Aug; 17(4 Suppl 7):11-3. PubMed ID: 2166344
[TBL] [Abstract][Full Text] [Related]
15. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
16. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
18. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
[TBL] [Abstract][Full Text] [Related]
20. [Drug therapy in bronchial carcinoma].
Manegold C; Drings P
Schweiz Med Wochenschr; 1995 Jul; 125(29):1396-405. PubMed ID: 7545824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
